The BNJ Biopharma team includes competent leaders with deep and extensive industry experience. Led by Chief Executive Officer, Jae June Dong, BNJ Biopharma operates AI-based new drug discovery in Korea
Chief Executive Officer
The BNJ Biopharma Lab focuses on discovering, developing and commercializing new medicines that can improve patients' lives. The relentless pursuit of global expertise is driving efforts to identify new molecules with the potential to get better patient life, improve healthcare and build sustainable value. We are committed to having a positive impact on the lives of patients with serious medical needs.